Adams Diversified Equity FundNYSE: ADX

Using diversified funds to gain wide exposure and strong income can be a winning income strategy. One of our picks gives exposure to REITs which are primed to strongly benefit from rate cuts. The other pick has over half a century of strong returns and NAV appreciation.

In the trading world, having the right tools and knowing how to use them correctly can be the difference between success and failure. One such tool is the Average Directional Index (ADX), which is acknowledged as a fundamental indicator for assessing the strength and direction of market trends.

The Adams Diversified Equity Fund has been operating since 1929, offering consistent distributions with a current yield of 6.28%. ADX has historically delivered returns in line with or exceeding the S&P 500, generating slight alpha over the broader market. The investment case for ADX centers on accessing S&P 500-like risks and returns, with primary returns driven by distributions rather than price appreciation.

The broader equity market saw declines in early August but ended near all-time highs to finish off the month. I put some capital to work this month at the low, but not as much as I had planned initially, as the market swiftly recovered. Most of the moves this month were corporate action-driven events, primarily the BlackRock tender offers, as we finished up the first measurement period.

Workplaces and stress related to them are a top 5 causes of death in the U.S.; dividends have caused zero fatalities. We look at how dividends can provide for you and your loved ones, without trading your health for wealth. True wealth is one that is recurring, even if you're not working.

Q32 Bio's Bempikibart and ADX-097 are in Phase 2 trials, targeting autoimmune and inflammatory diseases, with significant potential to address unmet medical needs. The company's unique approach of localized inhibition minimizes side effects and enhances efficacy, differentiating it in the biotech sector. Despite a short cash runway, Q32 Bio's recent merger, strategic reacquisition, and $42 million private placement bolstered its financial position.

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper draw-downs than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer “excess” discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

Every month, I add or initiate new positions in my closed-end fund portfolio. This creates a snowball of growing monthly cash flow over time. With the market continuing to perform well at/near all-time highs, letting some cash build up also doesn't hurt.

BALTIMORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Adams Diversified Equity Fund, Inc. (NYSE: ADX) announced today the final results of its offer to purchase up to 12,405,174 of its common shares at $22.47, 98% of the $22.93 net asset value per share (“NAV”) at the close of regular trading on the New York Stock Exchange on August 2, 2024, the expiration date (“Offer”), which include an updated proration factor. No other information about the Offer results has changed.